Refametinib 25 mg | 99.53%
TargetMol
Refametinib (RDEA119, Bay 86-9766) is an effective, ATP non-competitive and specific inhibitor of MEK1/2 (IC50: 19/47 nM).
More Information Supplier PageSearch Results
Refametinib 2 mg | 99.53%
TargetMol
Refametinib (RDEA119, Bay 86-9766) is an effective, ATP non-competitive and specific inhibitor of MEK1/2 (IC50: 19/47 nM).
More Information Supplier PageNodinitib-1 200 mg | 99.98%
TargetMol
Nodinitib-1 (CID-1088438) is a potent and selective NOD1 inhibitor with an IC50 of 0.56 μM.
More Information Supplier PageNodinitib-1
Nodinitib-1 100 mg | 99.98%
TargetMol
Nodinitib-1 (CID-1088438) is a potent and selective NOD1 inhibitor with an IC50 of 0.56 μM.
More Information Supplier PageNodinitib-1
Nodinitib-1 25 mg | 99.98%
TargetMol
Nodinitib-1 (CID-1088438) is a potent and selective NOD1 inhibitor with an IC50 of 0.56 μM.
More Information Supplier PageNodinitib-1
MRS 2578 100 mg | Purity Not Available
TargetMol
MRS2578, an effective P2Y6 receptor antagonist with IC50 of 37 nM, shows insignificant inhibition at P2Y1, P2Y2, P2Y4, and P2Y11 receptors.
More Information Supplier PageMRS 2578
YH239-EE 100 mg | 99.61%
TargetMol
YH239-EE, the ethyl ester of YH239, is a potent p53-MDM2 antagonist and an apoptosis inducer.
More Information Supplier PageSkepinone-L 2 mg | 99.76%
TargetMol
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.
More Information Supplier PageSkepinone-L
Skepinone-L 1 mg | 99.76%
TargetMol
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.
More Information Supplier PageSkepinone-L
Dalcetrapib 25 mg | 97.99%
TargetMol
Dalcetrapib, a rhCETP inhibitor (IC50=0.2 μM), increases the plasma HDL cholesterol.
More Information Supplier PageDalcetrapib
